Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Orso, Francesca ^a   Corà, Davide ^a,b   Ubezio, Benedetta ^a,c   Provero, Paolo ^a   Caselle, Michele ^a   Taverna, Daniela ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN CLCP1; PROTEIN DCBLD2; PROTEIN ESDN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2A; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; OLIGODEOXYRIBONUCLEOTIDE; TRANSCRIPTION FACTOR AP 2;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE CONTROL; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; TRANSCRIPTION FACTOR BINDING SITE; ANIMAL; BIOLOGY; CHEMISTRY; COMPUTER PROGRAM; DNA SEQUENCE; DOWN REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; PROMOTER REGION; REPRODUCIBILITY; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; SOFTWARE; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 77953001199     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-355     Document Type: Article

References (74)

1. Wasserman WW, Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 2004, 5(4):276-287. 10.1038/nrg1315, 15131651.
2. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122(6):947-956. 10.1016/j.cell.2005.08.020, 16153702.
3. Bouvet P. Identification of nucleic acid high-affinity binding sequences of proteins by SELEX. Methods Mol Biol 2009, 543:139-150. full_text, 19378165.
4. Pollock J, Baule VJ, Rich CB, Ginsburg CD, Curtiss SW, Foster JA. Chick tropoelastin isoforms. From the gene to the extracellular matrix. J Biol Chem 1990, 265(7):3697-3702.
5. Chang LW, Nagarajan R, Magee JA, Milbrandt J, Stormo GD. A systematic model to predict transcriptional regulatory mechanisms based on overrepresentation of transcription factor binding profiles. Genome Res 2006, 16(3):405-413. 10.1101/gr.4303406, 1415218, 16449500.
6. Ostrin EJ, Li Y, Hoffman K, Liu J, Wang K, Zhang L, Mardon G, Chen R. Genome-wide identification of direct targets of the Drosophila retinal determination protein Eyeless. Genome research 2006, 16(4):466-476. 10.1101/gr.4673006, 1457028, 16533912.
7. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer research 2009, 69(2):709-717. 10.1158/0008-5472.CAN-08-3415, 2629396, 19147588.
8. Cheng C, Ying K, Xu M, Zhao W, Zhou Z, Huang Y, Wang W, Xu J, Zeng L, Xie Y, et al. Cloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1). The international journal of biochemistry & cell biology 2002, 34(1):78-86. 10.1016/S1357-2725(01)00098-X, 11733187.
9. Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD. Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 2001, 276(44):40755-40760. 10.1074/jbc.M106284200, 11522791.
10. Feng W, Williams T. Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb. Molecular and cellular neurosciences 2003, 24(2):460-475. 10.1016/S1044-7431(03)00209-4, 14572467.
11. Wang HV, Vaupel K, Buettner R, Bosserhoff AK, Moser M. Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon. Dev Dyn 2004, 231(1):128-135. 10.1002/dvdy.20119, 15305293.
12. Hilger-Eversheim K, Moser M, Schorle H, Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 2000, 260(1-2):1-12. 10.1016/S0378-1119(00)00454-6, 11137286.
13. Werling U, Schorle H. Transcription factor gene AP-2 gamma essential for early murine development. Mol Cell Biol 2002, 22(9):3149-3156. 10.1128/MCB.22.9.3149-3156.2002, 133770, 11940672.
14. Eckert D, Buhl S, Weber S, Jager R, Schorle H. The AP-2 family of transcription factors. Genome biology 2005, 6(13):246. 10.1186/gb-2005-6-13-246, 1414101, 16420676.
15. Williams T, Tjian R. Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science New York, NY 1991, 251(4997):1067-1071.
16. Mohibullah N, Donner A, Ippolito JA, Williams T. SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex. Nucleic acids research 1999, 27(13):2760-2769. 10.1093/nar/27.13.2760, 148486, 10373594.
17. Gaynor RB, Muchardt C, Xia YR, Klisak I, Mohandas T, Sparkes RS, Lusis AJ. Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter. Genomics 1991, 10(4):1100-1102. 10.1016/0888-7543(91)90209-W, 1916817.
18. Gee MS, Sarkisian CJ, el-Deiry WS. Identification of a novel AP-2 consensus DNA binding site. Biochemical and biophysical research communications 1998, 243(1):307-316. 10.1006/bbrc.1997.8035, 9473523.
19. Stormo GD. DNA binding sites: representation and discovery. Bioinformatics, Oxford, England 2000, 16(1):16-23.
20. McPherson LA, Weigel RJ. AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic acids research 1999, 27(20):4040-4049. 10.1093/nar/27.20.4040, 148672, 10497269.
21. Wu F, Lee AS. YY1 as a regulator of replication-dependent hamster histone H3.2 promoter and an interactive partner of AP-2. J Biol Chem 2001, 276(1):28-34. 10.1074/jbc.M006074200, 11018030.
22. Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH. A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem 1998, 273(49):32957-32965. 10.1074/jbc.273.49.32957, 9830047.
23. McPherson LA, Loktev AV, Weigel RJ. Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53. J Biol Chem 2002, 277(47):45028-45033. 10.1074/jbc.M208924200, 12226108.
24. Pena P, Reutens AT, Albanese C, D'Amico M, Watanabe G, Donner A, Shu IW, Williams T, Pestell RG. Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA. Molecular endocrinology, Baltimore, Md 1999, 13(8):1402-1416.
25. Batsche E, Muchardt C, Behrens J, Hurst HC, Cremisi C. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 1998, 18(7):3647-3658. 108947, 9632747.
26. Sivak JM, West-Mays JA, Yee A, Williams T, Fini ME. Transcription Factors Pax6 and AP-2alpha Interact To Coordinate Corneal Epithelial Repair by Controlling Expression of Matrix Metalloproteinase Gelatinase B. Mol Cell Biol 2004, 24(1):245-257. 10.1128/MCB.24.1.245-257.2004, 303332, 14673159.
27. Wu F, Lee AS. CDP and AP-2 mediated repression mechanism of the replication-dependent hamster histone H3.2 promoter. Journal of cellular biochemistry 2002, 84(4):699-707. 10.1002/jcb.10094, 11835395.
28. Mori N, Prager D. High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax. Cancer research 1996, 56(4):779-782.
29. Somasundaram K, Jayaraman G, Williams T, Moran E, Frisch S, Thimmapaya B. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(7):3088-3093. 10.1073/pnas.93.7.3088, 39766, 8610173.
30. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer research 2004, 64(22):8256-8261. 10.1158/0008-5472.CAN-04-2055, 15548692.
31. Ding X, Fan C, Zhou J, Zhong Y, Liu R, Ren K, Hu X, Luo C, Xiao S, Wang Y, et al. GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation. Nucleic acids research 2006, 34(9):2570-2578. 10.1093/nar/gkl319, 16698963.
32. Kannan P, Yu Y, Wankhade S, Tainsky MA. PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic acids research 1999, 27(3):866-874. 10.1093/nar/27.3.866, 148259, 9889285.
33. Li Q, Dashwood RH. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells. J Biol Chem 2004, 279(44):45669-45675. 10.1074/jbc.M405025200, 2276578, 15331612.
34. Braganca J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC, Bhattacharya S. Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem 2003, 278(18):16021-16029. 10.1074/jbc.M208144200, 12586840.
35. Braganca J, Swingler T, Marques FI, Jones T, Eloranta JJ, Hurst HC, Shioda T, Bhattacharya S. Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2. J Biol Chem 2002, 277(10):8559-8565. 10.1074/jbc.M110850200, 11744733.
36. Kannan P, Tainsky MA. Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference. Mol Cell Biol 1999, 19(1):899-908. 83947, 9858613.
37. Campillos M, Garcia MA, Valdivieso F, Vazquez J. Transcriptional activation by AP-2alpha is modulated by the oncogene DEK. Nucleic acids research 2003, 31(5):1571-1575. 10.1093/nar/gkg247, 149840, 12595566.
38. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. The EMBO journal 1999, 18(9):2551-2562. 10.1093/emboj/18.9.2551, 1171336, 10228168.
39. Orso F, Penna E, Cimino D, Astanina E, Maione F, Valdembri D, Giraudo E, Serini G, Sismondi P, De Bortoli M, et al. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J 2008, 22(8):2702-2714. 10.1096/fj.08-106492, 18443366.
40. Wang T, Stormo GD. Combining phylogenetic data with co-regulated genes to identify regulatory motifs. Bioinformatics, Oxford, England 2003, 19(18):2369-2380.
41. Cora D, Di Cunto F, Caselle M, Provero P. Identification of candidate regulatory sequences in mammalian 3' UTRs by statistical analysis of oligonucleotide distributions. BMC Bioinformatics 2007, 8:174. 10.1186/1471-2105-8-174, 1904458, 17524134.
42. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES, Kellis M. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 2005, 434(7031):338-345. 10.1038/nature03441, 15735639.
43. Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, Kennedy BP, Wasserman WW. oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic acids research 2005, 33(10):3154-3164. 10.1093/nar/gki624, 1142402, 15933209.
44. Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 1994, 2:28-36.
45. Jolly ER, Chin CS, Herskowitz I, Li H. Genome-wide identification of the regulatory targets of a transcription factor using biochemical characterization and computational genomic analysis. BMC Bioinformatics 2005, 6:275. 10.1186/1471-2105-6-275, 1326232, 16297241.
46. Orso F, Jager R, Calogero RA, Schorle H, Sismondi P, De Bortoli M, Taverna D. AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase. BMC Biol 2009, 7:25. 10.1186/1741-7007-7-25, 2700071, 19463168.
47. Ruiz M, Pettaway C, Song R, Stoeltzing O, Ellis L, Bar-Eli M. Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Res 2004, 64(2):631-638. 10.1158/0008-5472.CAN-03-2751, 14744778.
48. Brose K, Tessier-Lavigne M. Slit proteins: key regulators of axon guidance, axonal branching, and cell migration. Curr Opin Neurobiol 2000, 10(1):95-102. 10.1016/S0959-4388(99)00066-5, 10679444.
49. Millette E, Rauch BH, Kenagy RD, Daum G, Clowes AW. Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 2006, 16(1):25-28. 10.1016/j.tcm.2005.11.003, 16387627.
50. Cha BY, Shi WL, Yonezawa T, Teruya T, Nagai K, Woo JT. An inhibitory effect of chrysoeriol on platelet-derived growth factor (PDGF)-induced proliferation and PDGF receptor signaling in human aortic smooth muscle cells. J Pharmacol Sci 2009, 110(1):105-110. 10.1254/jphs.08282FP, 19423953.
51. Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005, 96(7):379-386. 10.1111/j.1349-7006.2005.00062.x, 16053508.
52. Monypenny J, Zicha D, Higashida C, Oceguera-Yanez F, Narumiya S, Watanabe N. Cdc42 and Rac family GTPases regulate mode and speed but not direction of primary fibroblast migration during PDGF-dependent chemotaxis. Mol Cell Biol 2009, 2682035, 19273601.
53. Cho MC, Lee K, Paik SG, Yoon DY. Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR Res 2008, 2008:679137. 2430035, 18566691.
54. Boutros T, Chevet E, Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 2008, 60(3):261-310. 10.1124/pr.107.00106, 18922965.
55. Salanga CL, O'Hayre M, Handel T. Modulation of chemokine receptor activity through dimerization and crosstalk. Cell Mol Life Sci 2009, 66(8):1370-1386. 10.1007/s00018-008-8666-1, 2738873, 19099182.
56. Dhawan P, Richmond A. Role of CXCL1 in tumorigenesis of melanoma. Journal of leukocyte biology 2002, 72(1):9-18. 2668262, 12101257.
57. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007, 98(5):621-628. 10.1111/j.1349-7006.2007.00434.x, 17355265.
58. Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. The EMBO journal 2003, 22(10):2411-2421. 10.1093/emboj/cdg231, 155989, 12743035.
59. Yin T, Yang YC. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J Biol Chem 1994, 269(5):3731-3738.
60. Mitchell DC, Abdelrahim M, Weng J, Stafford LJ, Safe S, Bar-Eli M, Liu M. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1. J Biol Chem 2006, 281(1):51-58. 10.1074/jbc.M506245200, 16260418.
61. Liu R, Zhou A, Ren D, He A, Hu X, Zhang W, Yang L, Liu M, Li H, Zhou J, et al. Transcription factor specificity protein 1 (SP1) and activating protein 2alpha (AP-2alpha) regulate expression of human KCTD10 gene by binding to proximal region of promoter. The FEBS journal 2009, 276(4):1114-1124. 10.1111/j.1742-4658.2008.06855.x, 19154347.
62. Koshikawa K, Osada H, Kozaki K, Konishi H, Masuda A, Tatematsu Y, Mitsudomi T, Nakao A, Takahashi T. Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene 2002, 21(18):2822-2828. 10.1038/sj.onc.1205405, 11973641.
63. Nagai H, Sugito N, Matsubara H, Tatematsu Y, Hida T, Sekido Y, Nagino M, Nimura Y, Takahashi T, Osada H. CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells. Oncogene 2007, 26(27):4025-4031. 10.1038/sj.onc.1210183, 17213806.
64. Kim M, Lee KT, Jang HR, Kim JH, Noh SM, Song KS, Cho JS, Jeong HY, Kim SY, Yoo HS, et al. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion. Mol Cancer Res 2008, 6(2):222-230. 10.1158/1541-7786.MCR-07-0142, 18314483.
65. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436(7050):518-524. 10.1038/nature03799, 1283098, 16049480.
66. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS biology 2004, 2(2):E7. 10.1371/journal.pbio.0020007, 314300, 14737219.
67. Hubbard TJ, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y, Clarke L, Coates G, Cunningham F, Cutts T, et al. Ensembl 2007. Nucleic acids research 2007, (35 Database):D610-617. 10.1093/nar/gkl996, 1761443, 17148474.
68. Re A, Cora D, Taverna D, Caselle M. Genome-wide survey of microRNA-transcription factor feed-forward regulatory circuits in human. Mol Biosyst 2009, 5(8):854-867. 10.1039/b900177h, 19603121.
69. Vallania F, Schiavone D, Dewilde S, Pupo E, Garbay S, Calogero R, Pontoglio M, Provero P, Poli V. Genome-wide discovery of functional transcription factor binding sites by comparative genomics: the case of Stat3. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(13):5117-5122. 10.1073/pnas.0900473106, 2664024, 19282476.
70. van Helden J, Andre B, Collado-Vides J. Extracting regulatory sites from the upstream region of yeast genes by computational analysis of oligonucleotide frequencies. Journal of molecular biology 1998, 281(5):827-842. 10.1006/jmbi.1998.1947, 9719638.
71. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125(1-2):279-284. 10.1016/S0166-4328(01)00297-2, 11682119.
72. Cora D, Herrmann C, Dieterich C, Di Cunto F, Provero P, Caselle M. Ab initio identification of putative human transcription factor binding sites by comparative genomics. BMC Bioinformatics 2005, 6:110. 10.1186/1471-2105-6-110, 1097714, 15865625.
73. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 1996, 13(8):1701-1707.
74. Bosher JM, Williams T, Hurst HC. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(3):744-747. 10.1073/pnas.92.3.744, 42696, 7846046.